Gene · 3804
Papers2,392
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,392
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-resolution characterization of KIR genes polymorphism in healthy subjects from the Bulgarian population-A pilot study. | HLA | 2024 | 38180282 | PubTator, text mining | PubMed |
| NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer. | J Exp Clin Cancer Res | 2024 | 38167224 | PubTator, text mining | PubMed |
| Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML. | Blood Adv | 2024 | 38052043 | PubTator, text mining | PubMed |
| Association study between killer immunoglobulin-like receptor polymorphisms and susceptibility to COVID-19 disease: a systematic review and meta-analysis. | Immunol Res | 2024 | 37874432 | PubTator, text mining | PubMed |
| Immunological Aspects of Infertility-The Role of KIR Receptors and HLA-C Antigen. | Cells | 2023 | 38201263 | PubTator, text mining | PubMed |
| The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy. | Front Immunol | 2023 | 38162657 | PubTator, text mining | PubMed |
| Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse". | Int J Mol Sci | 2023 | 38139149 | PubTator, text mining | PubMed |
| Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma. | BMC Cancer | 2023 | 38114959 | PubTator, text mining | PubMed |
| Unraveling the Phenotypic States of Human innate-like T Cells: Comparative Insights with Conventional T Cells and Mouse Models. | bioRxiv | 2023 | 38105962 | PubTator, text mining | PubMed |
| PKM2 is a potential prognostic biomarker and related to immune infiltration in lung cancer. | Sci Rep | 2023 | 38097666 | PubTator, text mining | PubMed |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy. | Front Immunol | 2023 | 38090565 | PubTator, text mining | PubMed |
| Genome tuning through HLA and KIR gene clusters impact susceptibility to dengue. | Infect Med (Beijing) | 2023 | 38073888 | PubTator, text mining | PubMed |
| Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker. | Int J Mol Sci | 2023 | 38069309 | PubTator, text mining | PubMed |
| CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects. | Cells | 2023 | 38067178 | PubTator, text mining | PubMed |
| Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations. | Nat Commun | 2023 | 38042900 | PubTator, text mining | PubMed |
| Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders. | Haematologica | 2023 | 38037802 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors for multiple myeloma immunotherapy. | Exp Hematol Oncol | 2023 | 38017516 | PubTator, text mining | PubMed |
| Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing. | Int J Mol Sci | 2023 | 38003562 | PubTator, text mining | PubMed |
| Exploration of biomarkers for systemic lupus erythematosus by machine-learning analysis. | BMC Immunol | 2023 | 37950194 | PubTator, text mining | PubMed |
| An integrated study to decipher immunosuppressive cellular communication in the PDAC environment. | NPJ Syst Biol Appl | 2023 | 37945567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3804/papers?page=5